Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500096089Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial in Endometrial hypotrophy comparing Medical recombinant collagen care solution with Control: Non-recombinant collagen solution (placebo) (2 arms). Primary endpoint: Endometrial thickness. Planned start Feb 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500096089.